Bio-Rad Laboratories, Inc.Bio-Rad Laboratories, Inc.Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪8.63 B‬USD
−10.33USD
‪−637.32 M‬USD
‪2.67 B‬USD
‪19.70 M‬
Beta (1Y)
1.68

About Bio-Rad Laboratories, Inc.

CEO
Norman D. Schwartz
Headquarters
Hercules
Employees (FY)
‪8.03 K‬
Founded
1952
FIGI
BBG000DY28W5
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of BIO is 305.22 USD — it has increased by 1.09% in the past 24 hours. Watch Bio-Rad Laboratories, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Bio-Rad Laboratories, Inc. stocks are traded under the ticker BIO.
BIO stock has risen by 0.25% compared to the previous week, the month change is a 6.02% rise, over the last year Bio-Rad Laboratories, Inc. has showed a 26.11% decrease.
We've gathered analysts' opinions on Bio-Rad Laboratories, Inc. future price: according to them, BIO price has a max estimate of 402.00 USD and a min estimate of 300.00 USD. Watch BIO chart and read a more detailed Bio-Rad Laboratories, Inc. stock forecast: see what analysts think of Bio-Rad Laboratories, Inc. and suggest that you do with its stocks.
BIO reached its all-time high on Sep 2, 2021 with the price of 832.70 USD, and its all-time low was 0.87 USD and was reached on Aug 19, 1982. View more price dynamics on BIO chart.
See other stocks reaching their highest and lowest prices.
BIO stock is 3.21% volatile and has beta coefficient of 1.68. Track Bio-Rad Laboratories, Inc. stock price on the chart and check out the list of the most volatile stocks — is Bio-Rad Laboratories, Inc. there?
Today Bio-Rad Laboratories, Inc. has the market capitalization of ‪8.61 B‬, it has increased by 10.57% over the last week.
Yes, you can track Bio-Rad Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.
Bio-Rad Laboratories, Inc. is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
BIO earnings for the last quarter are 2.29 USD per share, whereas the estimation was 2.15 USD resulting in a 6.69% surprise. The estimated earnings for the next quarter are 2.01 USD per share. See more details about Bio-Rad Laboratories, Inc. earnings.
Bio-Rad Laboratories, Inc. revenue for the last quarter amounts to ‪610.80 M‬ USD, despite the estimated figure of ‪619.09 M‬ USD. In the next quarter, revenue is expected to reach ‪645.79 M‬ USD.
BIO net income for the last quarter is ‪383.92 M‬ USD, while the quarter before that showed ‪349.71 M‬ USD of net income which accounts for 9.78% change. Track more Bio-Rad Laboratories, Inc. financial stats to get the full picture.
No, BIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 24, 2024, the company has ‪8.03 K‬ employees. See our rating of the largest employees — is Bio-Rad Laboratories, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bio-Rad Laboratories, Inc. EBITDA is ‪567.97 M‬ USD, and current EBITDA margin is 21.57%. See more stats in Bio-Rad Laboratories, Inc. financial statements.
Like other stocks, BIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bio-Rad Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bio-Rad Laboratories, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bio-Rad Laboratories, Inc. stock shows the sell signal. See more of Bio-Rad Laboratories, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.